In addition, inhibition of ETK activity enhanced ROS production and cytotoxicity in bladder cancer cells in response to treatment of Doxorubucin, while overexpression of ETK had protective effects (Fig. 3B & 3C). The gene discussed is BMX; the disease is urinary bladder carcinoma.